Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Alnylam Pharmaceuticals, Inc.
| Okres |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
2,875.65 |
3,764.47 |
4,890.11 |
6,334.77 |
7,828.47 |
| Przychód Δ r/r |
0.00% |
30.91% |
29.90% |
29.54% |
23.58% |
| Przychód (min) |
2,612.14 |
2,799.53 |
4,883.84 |
5,215.95 |
6,445.85 |
| Przychód (max) |
3,322.46 |
6,217.59 |
4,896.38 |
8,698.20 |
10,749.18 |
| EBITDA (średnia) |
-1,666.44 |
-2,181.51 |
-2,833.82 |
-3,671.00 |
-4,536.60 |
| EBIT (średnia) |
-1,754.99 |
-2,297.44 |
-2,984.41 |
-3,866.08 |
-4,777.68 |
| EBIT % |
-61.03% |
-61.03% |
-61.03% |
-61.03% |
-61.03% |
| Zysk netto (średni) |
-108.99 |
169.29 |
832.56 |
1,448.52 |
2,104.97 |
| Zysk netto % |
-3.79% |
4.50% |
17.03% |
22.87% |
26.89% |
| EPS (średnia) |
-0.85 |
1.83 |
7.14 |
11.35 |
16.49 |
| Liczba analityków (Przychody) |
21 |
30 |
23 |
14 |
11 |
| Liczba analityków (EPS) |
13 |
21 |
20 |
11 |
10 |
| symbol |
ALNY |
ALNY |
ALNY |
ALNY |
ALNY |